Inventor · disambiguated record
Peter Thaddeus Gallagher
Also filed as: GALLAGHER PETER · GALLAGHER PETER T · GALLAGHER PETER THADDEUS
33 granted patents·1 pending application·208 citations·filing 1987–2014
96Inventor score
Top patents by PatentIndex Score
34 records- 0192US7384941B22-(phenoxymethyl)-and 2-(phenylthiomethyl)-morpholine derivatives for use as selective norepinephrine reuptake inhibitorsLILLY CO ELI·Filed 2003·Granted Jun 10, 2008·46 cites·8 claims
- 0280US5563147ASerotonerbic tetrahydropyridoindolesLILLY CO ELI·Filed 1995·Granted Oct 8, 1996·29 cites·8 claims
- 0374US6844338B2Piperidyindoles as serotonin receptor ligandsLILLY CO ELI·Filed 2001·Granted Jan 18, 2005·7 cites·8 claims
- 0473US7910588B25-HT7 receptor antagonistsLILLY CO ELI·Filed 2008·Granted Mar 22, 2011·2 cites·7 claims
- 0571US7037932B2Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitorsLILLY CO ELI·Filed 2002·Granted May 2, 2006·8 cites·46 claims
- 0670US7619096B23-Aminopyrrolidines as inhibitors of monoamine uptakeLILLY CO ELI·Filed 2004·Granted Nov 17, 2009·6 cites·5 claims
- 0769US7432280B23-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptakeLILLY CO ELI·Filed 2004·Granted Oct 7, 2008·5 cites·11 claims
- 0868US6166040AIndole compoundsLILLY CO ELI·Filed 1999·Granted Dec 26, 2000·27 cites·8 claims
- 0963US7488728B2Pyridinylmorpholine derivativesLILLY CO ELI·Filed 2004·Granted Feb 10, 2009·1 cites·15 claims
- 1061US7294623B2Benzyl morpholine derivativesLILLY CO ELI·Filed 2003·Granted Nov 13, 2007·2 cites·7 claims
- 1161US5480873APharmaceutical compoundsLILLY INDUSTRIES LTD·Filed 1993·Granted Jan 2, 1996·17 cites·9 claims
- 1259US6329366B1Pharmaceutical compoundsLILLY CO ELI·Filed 1999·Granted Dec 11, 2001·16 cites·10 claims
- 1354US9562057B2(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonistsLILLY CO ELI·Filed 2014·Granted Feb 7, 2017·0 cites·7 claims
- 1451US7521462B24-Amino-piperidine derivatives as monoamine uptake inhibitorsLILLY CO ELI·Filed 2005·Granted Apr 21, 2009·0 cites·2 claims
- 1550US6075039A5HT receptor binding benzimidazolylpiperidinesLILLY CO ELI·Filed 1997·Granted Jun 13, 2000·4 cites·6 claims
- 1650US4892963AN-phenyl amide compoundsLILLY INDUSTRIES LTD·Filed 1987·Granted Jan 9, 1990·7 cites·9 claims
- 1748US5668172AAnthraquinone pharmaceutical compounds and uses thereforLILLY INDUSTRIES LTD·Filed 1995·Granted Sep 16, 1997·6 cites·7 claims
- 1847US7615648B2Aminomethyl-azacycle derivatives as inhibitors of monoamine uptakeLILLY CO ELI·Filed 2005·Granted Nov 10, 2009·0 cites·7 claims
- 1947US7410982B2Propanamine derivatives as serotonin and norepinephrine reuptake inhibitorsLILLY CO ELI·Filed 2003·Granted Aug 12, 2008·0 cites·4 claims
- 2047US7410996B23-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptakeLILLY CO ELI·Filed 2003·Granted Aug 12, 2008·0 cites·3 claims
- 2147US5378699AMethods of using dihydropyransLILLY INDUSTRIES LTD·Filed 1993·Granted Jan 3, 1995·5 cites·8 claims
- 2245US7595315B2Morpholine derivatives as norepinephrine reuptake inhibitorsLILLY CO ELI·Filed 2004·Granted Sep 29, 2009·0 cites·3 claims
- 2344US7417064B23-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptakeLILLY CO ELI·Filed 2003·Granted Aug 26, 2008·0 cites·5 claims
- 2444US5663375APharmaceutical compoundsLILLY CO ELI·Filed 1994·Granted Sep 2, 1997·4 cites·8 claims
- 2543US5773448APharmaceutical compoundsLILLY CO ELI·Filed 1997·Granted Jun 30, 1998·5 cites·6 claims
- 2640US2006079554A1Inhibitors of monomine uptakeBARRY PETER C·Filed 2003·Application pending·0 cites
- 2739US8202873B22-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonistsBADESCU VALENTINA O·Filed 2008·Granted Jun 19, 2012·0 cites·9 claims
- 2839US4983619APharmaceutical compoundsLILLY INDUSTRIES LTD·Filed 1990·Granted Jan 8, 1991·3 cites·8 claims
- 2938US5792797APharmaceutical compoundsLILLY INDUSTRIES LTD·Filed 1997·Granted Aug 11, 1998·2 cites·6 claims
- 3037US8314092B2Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonistsCAMP ANNE MARIE·Filed 2012·Granted Nov 20, 2012·0 cites·15 claims
- 3137US5622987A5,6-dihydronaphtho [1,2-b]pyrans and their use as pharmaceutical compoundsLILLY CO ELI·Filed 1995·Granted Apr 22, 1997·2 cites·6 claims
- 3234US5430067APharmaceutical compoundsLILLY CO ELI·Filed 1994·Granted Jul 4, 1995·1 cites·3 claims
- 3332US5378717ATherapy for diabetic complicationsLILLY CO ELI·Filed 1993·Granted Jan 3, 1995·3 cites·10 claims
- 3430US5484935APharmaceutical compoundsLILLY INDUSTRIES LTD·Filed 1994·Granted Jan 16, 1996·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →